Oxaliplatin in Gastric Cancer
NCT00263354
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Stomach Neoplasms
Interventions
DRUG:
Oxaliplatin
Sponsor
Sanofi